Sort
51,593 grants matching “hepatitis”
Gulf Longitudinal Follow-up (GuLF) Study
$1,209,935Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES
Preclinical Development of a Thermostable Trivalent Filovirus Vaccine
$1,209,712Axel T Lehrer · University Of Hawaii At Manoa · R01 · FY2019 · AI
Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU)
$1,209,654Suwat Chariyalertsak · Chiang Mai University · UM1 · FY2016 · AI
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
$1,209,546Andrea L Cox · Johns Hopkins University · U19 · FY2022 · AI
Nuclear receptors: action, functions, and roles in disease
$1,209,453Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES
Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Markets and Drug Tourism
$1,208,754Steffanie A Strathdee · University Of California, San Diego · R01 · FY2021 · DA
Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care
$1,208,520Bruce R Schackman · Weill Medical Coll Of Cornell Univ · P30 · FY2015 · DA
Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury
$1,207,542Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2013 · AA
VANDERBILT ADULT AIDS CLINICAL TRIALS UNIT
$1,207,252Vanderbilt University · U01 · FY2002 · AI
Molecular Biology of Hemorrhagic Shock
$1,207,076Timothy R Billiar · University Of Pittsburgh At Pittsburgh · P50 · FY2012 · GM
INTERNATIONAL TRAINING GRANT IN EPIDEMIOLOGY RELATED TO
$1,206,496University Of California Los Angeles · D43 · FY2001 · TW
DEVELOPMENT OF NOVEL THERAPIES FOR NIDDM
$1,206,169University Of Texas Sw Med Ctr/Dallas · P01 · FY2003 · DK
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study
$1,206,083Philip Todd Korthuis · Oregon Health & Science University · UH3 · FY2020 · DA
Macaque and human models for preclinical development of iPSCs
$1,205,414Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
Studies of Rare Cancers
$1,205,252Louise Brinton · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
Molecular Subtypes for Targeted Therapies in Alcoholic Hepatitis
$1,205,194Ramon Bataller · Univ Of North Carolina Chapel Hill · U01 · FY2016 · AA
Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors
$1,204,486Kenner Rice · National Institute On Drug Abuse · ZIA · FY2013 · DA
Preclinical Development of a Thermostable Trivalent Filovirus Vaccine
$1,203,584Axel T Lehrer · University Of Hawaii At Manoa · R01 · FY2020 · AI
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases
$1,203,264Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Addressing alcohol misuse in HIV prevention and care: The Brown University Alcohol Research Center on HIV (ARCH)
$1,203,071Christopher W. Kahler · Brown University · P01 · FY2022 · AA
DETERMINANTS OF INDIVIDUAL RESPONSIVENESS TO DRUGS
$1,202,331Vanderbilt University · P01 · FY2004 · GM
Mechanisms of Alcoholic Liver Disease
$1,202,007Bin Gao · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2010 · AA
Center for CAM Research on Autoimmune and Inflammatory Diseases
$1,201,975Prakash S. Nagarkatti · University Of South Carolina At Columbia · P01 · FY2007 · AT
Innate immunity and cytokines in liver diseases
$1,201,402Bin Gao · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2014 · AA
Immunologic Mechanisms of Alcoholic Liver Disease
$1,201,402Bin Gao · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2014 · AA